Intersect ENT to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Intersect ENT (Nasdaq: XENT) announced that CEO Tom West and CFO Randy Meier will participate in two upcoming investor conferences. The BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference will feature a fireside chat on February 17, 2021, at 11:30 a.m. ET. This will be followed by a fireside chat at the SVB Leerink Virtual 10th Annual Global Healthcare Conference on February 26, 2021, at 1:00 p.m. ET. A live webcast can be accessed via their website, where a replay will also be available after each event.

Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that Tom West, President & Chief Executive Officer, and Randy Meier, Executive Vice President & Chief Financial Officer, will participate in the following upcoming investor conferences:

• BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
  Fireside Chat: Wednesday, February 17, 2021 at 11:30 a.m. ET / 8:30 a.m. PT.

• SVB Leerink Virtual 10^th Annual Global Healthcare Conference
  Fireside Chat: Friday, February 26, 2021 at 1:00 p.m. ET / 10:00 a.m. PT.

A live webcast of the fireside chats can be accessed by visiting the “Investor Relations” page of the Company’s website at www.intersectENT.com. A replay will be available on the Company’s website following the event.

About Intersect ENT

Intersect ENT is a global ear, nose and throat medical technology leader dedicated to transforming patient care. The Company’s steroid releasing implants are designed to provide mechanical spacing and deliver targeted therapy to the site of disease. In addition, Intersect ENT is continuing to expand its portfolio of products based on the Company’s unique localized steroid releasing technology and is committed to broadening patient access to less invasive and more cost-effective care. In October 2020, Intersect ENT acquired Fiagon AG Medical Technologies, a global leader in electromagnetic surgical navigation solutions with an expansive portfolio of ENT product offerings, including the VENSURE sinus dilation balloon, that complement the Company’s PROPEL^® and SINUVA^® sinus implants and extend its geographic reach.

For additional information on the Company or the products including risks and benefits please visit www.IntersectENT.com. For more information about PROPEL^® (mometasone furoate) sinus implants and SINUVA^® (mometasone furoate) sinus implant, please visit www.PROPELOPENS.com and www.SINUVA.com.

Intersect ENT^®, PROPEL^® and SINUVA^® are registered trademarks of Intersect ENT, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210201005126/en/

FAQ

When will Intersect ENT participate in the BTIG Virtual MedTech Conference?

Intersect ENT will participate in the BTIG Virtual MedTech Conference fireside chat on February 17, 2021, at 11:30 a.m. ET.

What is the date of the SVB Leerink Virtual 10th Annual Global Healthcare Conference?

The SVB Leerink Virtual 10th Annual Global Healthcare Conference will take place on February 26, 2021, with a fireside chat at 1:00 p.m. ET.

Where can I watch the live webcasts for Intersect ENT's investor conferences?

The live webcasts for Intersect ENT's investor conferences can be accessed on the 'Investor Relations' page of their website.

What products does Intersect ENT offer?

Intersect ENT offers steroid releasing implants such as PROPEL® and SINUVA®, which target disease sites in ENT care.

What recent acquisition did Intersect ENT make?

In October 2020, Intersect ENT acquired Fiagon AG Medical Technologies, expanding its portfolio and geographic reach in ENT solutions.